Free public records show Avet Lifesciences in 4 of the markets we cover. It is not a key player in our research.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
26 approvals with a product on the US market
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.
4 recalls since 2015 (4 for medicines)
Source: openFDA, FDA enforcement reports (recalls) naming the firm, since 2015. Retrieved 13 Nov 2026.
Markets we cover where free public records show Avet Lifesciences: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Avet Lifesciences is in.
Stories on the topics Avet Lifesciences works in.
TB killed 1.23 million people in 2024. WHO now recommends rapid molecular tests first, bringing lab-grade…
Read
WHO says only about half of patients in developed countries take long-term medicines as prescribed. Patient…
Read
Drug-resistant infections already kill over a million people a year. Faster testing helps doctors pick the…
Read